EUVIMEDEUVIMED entdecken
KommentarOpen Access · CC BY 4.0

The interplay between eosinophils and T cells in breast cancer immunotherapy

Ioannis Zerdes iD, Alexios Matikas, Theodoros Foukakis

Molecular Oncology · 2023

DOI: 10.1002/1878-0261.13413 ↗

Kurz gefasst

Kommentar in der Zeitschrift Molecular Oncology, 2023. Verfasst von Ioannis Zerdes und 2 weiteren Autor:innen. Beteiligte Einrichtung: Breast Center, Theme Cancer, Karolinska University Hospital and Karolinska Comprehensive Cancer Center, Stockholm, Sweden. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Iris, Stig och Gerry Castenbäcks Foundation, Region Stockholm (clinical postdoctorial appointment), Swedish Cancer Society (Cancerfonden) Junior Clinical Investigator Award.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Treatment with immune checkpoint inhibitors (ICI) has revolutionized cancer management for multiple tumor types, including breast cancer. However, not all patients respond to ICI, and unraveling the determinants and mechanisms of response still remains an unmet need. A recent study has uncovered the critical role of eosinophils in mediating immunotherapy effect in breast cancer, mainly by stimulating the activation of CD8+ T‐cells. Furthermore, the intratumoral eosinophil recruitment was directed by CD4+ T cells and the interleukins IL‐5 and IL‐33, thus providing the rationale for targeting eosinophils to enhance ICI response.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsHumansFemaleEosinophilsImmunotherapyCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesTumor Microenvironment

Stichwörter der Autor:innen

T cellsbreast cancereosinophilsimmunotherapytumor microenvironment

Autor:innen und Institutionen

  • Breast Center, Theme Cancer, Karolinska University Hospital and Karolinska Comprehensive Cancer Center, Stockholm, Sweden.
  • Department of Oncology/Pathology, Karolinska Institutet, Stockholm, Sweden.

ORCID-Profile: Ioannis Zerdes

Förderung

  • Iris, Stig och Gerry Castenbäcks Foundation
  • Region Stockholm (clinical postdoctorial appointment)
  • Swedish Cancer Society (Cancerfonden) Junior Clinical Investigator Award
  • Swedish Society of Oncology Postdoctoral Grant
  • Incorporated Research Institutions for Seismology
  • Cancerfonden

Zitieren

APA

Zerdes, I., Matikas, A., & Foukakis, T. (2023). The interplay between eosinophils and T cells in breast cancer immunotherapy. Molecular Oncology. https://doi.org/10.1002/1878-0261.13413

Vancouver

Zerdes I, Matikas A, Foukakis T. The interplay between eosinophils and T cells in breast cancer immunotherapy. Molecular Oncology. 2023. doi:10.1002/1878-0261.13413

BibTeX
@article{Zerdes2023,
  author = {Zerdes, Ioannis and Matikas, Alexios and Foukakis, Theodoros},
  title = {The interplay between eosinophils and T cells in breast cancer immunotherapy},
  journal = {Molecular Oncology},
  year = {2023},
  doi = {10.1002/1878-0261.13413}
}
Kostenlos starten →